Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T08:44:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T08:37:20.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the corresponding text and a Home button, indicating that access to the study record is blocked and the normal study details are not available.
    Difference
    0.5%
    Check dated 2026-09-29T08:39:43.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study details with an access-denied screen. The UI shows the error text and basic navigation (including Home and Revision: v3.7.0), while the substantive study information has been removed.
    Difference
    19%
    Check dated 2026-09-22T07:56:04.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.6, replacing the previous v3.6.5. This indicates a minor update to the page's revision tag, with no changes to the study details or criteria.
    Difference
    0.1%
    Check dated 2026-08-31T23:48:13.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.4 to v3.6.5, signaling a new build of the study details page. The update appears to be a backend or layout revision without changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-10T11:57:14.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.